Molecular-Targeted Therapies for Hematologic Malignancies

Molecular-Targeted Therapies for Hematologic Malignancies

Saved in:

Bibliographic Details
Main Authors:	Kevin D. Bunting, Cheng-Kui Qu, Michael H. Tomasson
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Advances in Hematology
Online Access:	http://dx.doi.org/10.1155/2012/606423
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lysosome targeted therapies in hematological malignancies
by: Madhumita S. Manivannan, et al.
Published: (2025-02-01)

Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
by: Jessica M. McDaniel, et al.
Published: (2012-01-01)

Engineered exosomes: advanced nanocarriers for targeted therapy and drug delivery in hematological malignancies
by: Mahsa Rahgoshay, et al.
Published: (2025-07-01)

Nonengraftment Haploidentical Cellular Therapy for Hematologic Malignancies
by: John L. Reagan, et al.
Published: (2012-01-01)

Advanced molecular diagnostics: Driving precision in hematological malignancies
by: Li Bao, et al.
Published: (2025-07-01)

Targeting myeloid cells for hematological malignancies: the present and future
by: Zihui Guan, et al.
Published: (2025-04-01)

THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES
by: Giovanni Roti, et al.
Published: (2019-06-01)

Lymphoid hematological malignancies
by: D. A. Domninskiy
Published: (2014-07-01)

Myeloid hematological malignancies
by: D. A. Domninsky
Published: (2014-07-01)

Candidiasis in hematologic malignancies
by: V. B. Larionova, et al.
Published: (2022-11-01)

Monitoring of patients with hematological malignancies after anticancer therapy
by: A. E. Rudneva, et al.
Published: (2015-01-01)

Molecular targets for metastasis-directed therapy in malignant tumors
by: V. V. Bodenko, et al.
Published: (2024-07-01)

Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies
by: Elvira Umyarova, et al.
Published: (2025-03-01)

CD19 -targeted CAR T therapy treating hematologic malignancies: hidden danger is the next neighbor to security?
by: Xueshuai Ye, et al.
Published: (2025-03-01)

Integrative cytogenetic and molecular studies unmask “chromosomal mimicry” in hematologic malignancies
by: Melissa Zhao, et al.
Published: (2025-03-01)

ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies
by: Jie Zhang, et al.
Published: (2025-07-01)

HEMATOLOGICAL MALIGNANCIES. LYMPHOCYTIC LEUKAEMIA
by: Peter F. Litvitsky, et al.
Published: (2016-11-01)

Eosinophilic Dermatosis of Hematological Malignancy
by: Shaurya Sahani, et al.
Published: (2025-03-01)

Editorial: Rare hematological malignancies
by: Pier Paolo Piccaluga, et al.
Published: (2025-04-01)

Aspergillosis in patients with hematological malignancies
by: N. B. Bulieva
Published: (2014-07-01)

Hypercalcemia associated with hematologic malignancies
by: I. A. Kurmukov, et al.
Published: (2022-11-01)

Molecular Insights into the Potential of Extracellular Vesicles Released from Mesenchymal Stem Cells and Other Cells in the Therapy of Hematologic Malignancies
by: Suliman A. Alsagaby
Published: (2021-01-01)

Significant Progress in CAR T-Cell Therapy for Difficult-to-Treat Hematologic Malignancies
by: Raphaël Stadelmann, et al.
Published: (2022-10-01)

Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
by: Haiqiong Zheng, et al.
Published: (2024-11-01)

Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
by: Yuheng Jin, et al.
Published: (2025-03-01)

Molecular Genetic Abnormalities in the Pathogenesis of Hematologic Malignancies and Corresponding Changes in Cell Signaling Systems
by: LR Tilova, et al.
Published: (2017-04-01)

Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
by: Sigrun Einarsdottir, et al.
Published: (2025-07-01)

Therapeutic Benefits of Lenalidomide in Hematological Malignancies
by: Mohammed Shafi Abdulsalam, et al.
Published: (2019-04-01)

Second tumors in children with hematological malignancies
by: N. A. Susuleva, et al.
Published: (2021-04-01)

Oral microflora in children with hematologic malignancies
by: M. F. Vecherkovskaya, et al.
Published: (2015-06-01)

The role of non-malignant B cells in malignant hematologic diseases
by: Daquan Gao
Published: (2025-12-01)

Total IgE levels in patients with hematologic malignancies
by: Parisa Amjadi, Ph.D, et al.
Published: (2025-05-01)

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies
by: Giovanni D’Arena, et al.
Published: (2017-01-01)

Targeting high-risk groups in the post-pandemic era: A focus on pediatric hematological malignancies
by: Nan-Chang Chiu, et al.
Published: (2024-11-01)

CSF@E‐Hn: A bone marrow‐targeted nanosystem for advanced treatment of hematological malignancies
by: Yinyan Jiang, et al.
Published: (2024-12-01)

DETERMINATION OF FREQUENCY AND RISK FACTORS OF SECONDARY MALIGNANCY DEVELOPMENT IN HEMATOLOGICAL MALIGNANCIES
by: Ennur Ramadan, et al.
Published: (2024-12-01)

Predictors of Poor Outcomes in Critically Ill Adults with Hematologic Malignancy
by: Marion Cornish, et al.
Published: (2016-01-01)

Epigenomic insights and computational advances in hematologic malignancies
by: Carolyn Lauzon-Young, et al.
Published: (2025-04-01)

Parthenolide: pioneering new frontiers in hematological malignancies
by: Elmira Zarei, et al.
Published: (2025-04-01)

COEXISTENCE OF RENAL CELL CARCINOMA AND HEMATOLOGICAL MALIGNANCIES
by: Gokhan Sargin, et al.
Published: (2014-08-01)